Placebo CagriSema

DRUG2 trials

Sponsors

Novo Nordisk A/S

Conditions

Diabetes Mellitus, Type 2ObesityOverweight

Phase 2

A Research Study to Compare Two Different Versions of Injectable CagriSema in People With Type 2 Diabetes

WithdrawnNCT07357740

Novo Nordisk A/SDiabetes Mellitus, Type 2

Start: 2026-08-27End: 2027-10-13Updated: 2026-07-09

Phase 3

A Research Study to Compare Different Versions of Injectable CagriSema and Placebo in People With Excess Body Weight

WithdrawnNCT07357766

Novo Nordisk A/SObesity, Overweight

Start: 2026-06-22End: 2028-01-17Updated: 2026-07-09